Participants in RCTs are usually selected based on specific eligibility criteria, such as type and stage of cancer, prior treatments, and overall health status. Once selected, participants are randomly assigned to either the experimental group (receiving the new treatment) or the control group (receiving standard treatment or a placebo). This randomization process is critical for reducing selection bias and ensuring the reliability of the results.
